Imperial College COVID-19 Response Team

Imperial College COVID-19 Response Team
Founded atImperial College London, Faculty of Medicine
HeadquartersLondon, England
ServicesReports relating to the COVID-19 pandemic to inform governments and public health agencies around the world
50 scientists
Professor Neil Ferguson
AffiliationsMRC GIDA, Jameel Institute

The Imperial College COVID-19 Response Team is a group of experts from Imperial College London studying the COVID-19 pandemic and informing the government of the United Kingdom, and governments and public health agencies around the world.[1][2][3] The team comprises scientists from the MRC Centre for Global Infectious Disease Analysis, the Jameel Institute, the Imperial College Business School and the Department of Mathematics.[4] The Imperial College COVID-19 Response Team is led by Professor Neil Ferguson, Director of the Jameel Institute and MRC GIDA.[5][6]

On 16 March 2020 the Imperial College COVID-19 Response Team produced a research forecast of various scenarios for spread of the disease in the United Kingdom and the United States. Without any mitigation their forecast showed local health care capabilities vastly overwhelmed by the epidemic wave. Periodic cycles of quarantine followed by softer social distancing were recommended, with quarantines in effect two-thirds of the time.[7] On 30 March, a study on 11 European countries was published.[8] It provided estimates of the situation as of 28 March (observed and modelised with CovidSim), and projections for 31 March given current expectations, no action, and the difference. It also provided a list of government policies and their respective absolute dates.[8] As of 2 May 2021, the Imperial College COVID-19 Response Team has produced 43 reports.[9]


COVID-19 reports
432021-03-24Quantifying the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic
422020-12-31Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data
412020-12-22The 2020 SARS-CoV-2 epidemic in England: key epidemiological drivers and impact of interventions
402020-12-10Optimal scheduling rules for elective care to minimize years of life lost during the SARS-CoV-2 pandemic: an application to England
392020-12-01Characterising COVID-19 epidemic dynamics and mortality under-ascertainment in Khartoum, Sudan
382020-11-27SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis
372020-11-25Children’s role in the COVID-19 pandemic: as systematic review of susceptibility, severity, and transmissibility
362020-11-16Modelling ICU capacity under different epidemiological scenarios of the COVID-19 pandemic in three western European countries
352020-11-16How can we keep schools and universities open? Differentiating closures by economic sector to optimize social and economic activity while containing SARS-CoV-2 transmission
342020-10-29Infection Fatality Ratio Estimates from Seroprevalence
332020-09-25Modelling the allocation and impact of a COVID-19 vaccine
322020-09-17Age groups that sustain resurging COVID-19 epidemics in the United States
312020-09-15Estimating under-ascertainment of COVID-19 mortality: an analysis of novel data sources to provide insight into COVID-19 dynamics in Damascus, Syria
302020-07-03The COVID-19 epidemic trends and control measures in mainland China
292020-07-01The impact of the COVID-19 epidemic on all-cause attendances to emergency departments in two large London hospitals: an observational study
282020-06-18Excess non-COVID-19 deaths in England and Wales between 29th February and 5th June 2020
272020-06-15Adapting hospital capacity to meet changing demands during the COVID-19 pandemic
262020-06-08Reduction in mobility and COVID-19 transmission
252020-05-29Response to COVID-19 in South Korea and implications for lifting stringent interventions
242020-05-29Anonymised & aggregated crowd level mobility data from mobile phones suggests initial compliance with COVID19 social distancing interventions was high & geographically consistent across UK
232020-05-21State-level tracking of COVID-19 in the United States
222020-05-12Equity in response to the COVID-19 pandemic: an assessment of the direct and indirect impacts on disadvantaged and vulnerable populations in low- and lower middle-income countries
212020-05-08Estimating COVID-19 cases and reproduction number in Brazil
202020-05-04Using mobility to estimate the transmission intensity of COVID-19 in Italy: A subnational analysis with future scenarios
192020-05-01The Potential Impact of the COVID-19 Epidemic on HIV, TB and Malaria in Low- and Middle-Income Countries
182020-05-01The potential public health impact of COVID-19 on malaria in Africa
172020-04-29Clinical characteristics and predictors of outcomes of hospitalised patients with COVID-19 in a London NHS Trust: a retrospective cohort study
162020-04-23Role of testing in COVID-19 control
The report estimates COVID-19 testing's impact as reducing transmission by 25~33% from populations tested, but also allowing early release from quarantines and creation of Immunity passport based on antibody tests. Tests face technical, legal, and ethical challenges. Tests while helping are complementary to other more potent actions such as self-isolation when symptoms arises, contact tracing and quarantines.
152020-04-17Strengthening hospital capacity for the COVID-19 pandemic
Reports presents the Jameel Institute pandemic planner "a hospital planning tool to calculate how much capacity in terms of beds, staff and ventilators is obtained by implementing healthcare provision interventions affecting the management of patient care in hospitals".
142020-04-03Online Community Involvement in COVID-19 Research & Outbreak Response: Early Insights from a UK Perspective
132020-03-30Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries
122020-03-26The global impact of COVID-19 and strategies for mitigation and suppression
112020-03-24Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment
102020-03-20Public response to UK Government recommendations on COVID-19: population survey, 17-18 March 2020
92020-03-16Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand
This report made an informed estimate of impact for both UK and the US, according to different strategies. The dire impact expressed helped convert the Jonhson government from laisser-faire to mitigative strategies.
82020-03-11Symptom progression of COVID-19
72020-03-09Estimating infection prevalence in Wuhan City from repatriation flights
62020-02-21Relative sensitivity of international surveillance
52020-02-15Phylogenetic analysis of SARS-CoV-2
42020-02-10Severity of 2019 novel coronavirus (nCoV)
32020-01-25Transmissibility of 2019-nCoV
22020-01-22Estimating the potential total number of novel Coronavirus (2019-nCoV) cases in Wuhan City, China
12020-01-17Estimating the potential total number of novel Coronavirus (2019-nCoV) cases in Wuhan City, China


11 European countries estimates on March 28, 2020

Population infected by country
ICCRT's model projection for March 28[8]WHO lab-confirmed March 29

(95% range)


(mean %)




(% of pop.)

United Kingdom67,803,4501.2%-5.4%2.7%1830700170930.03%
Note: WHO reporting laboratory-confirmed cases on March 29, 10am Central European Time.

World estimates for 3 strategies

Estimated impact of suppression strategies over 250 days for 3 different strategies.[10]
Unmitigated ScenarioSuppression at 0.2 deaths/100,000/weekSuppression at 1.6 deaths/100,000/week
East Asia & Pacific2,117,131,00015,303,00092,544,000442,000632,619,0003,315,000
Europe & Central Asia801,770,0007,276,00061,578,000279,000257,706,0001,397,000
Latin America & Caribbean566,993,0003,194,00045,346,000158,000186,595,000729,000
Middle East & North Africa419,138,0001,700,00030,459,000113,000152,262,000594,000
North America326,079,0002,981,00017,730,00092,00090,529,000520,000
South Asia1,737,766,0007,687,000111,703,000475,000629,164,0002,693,000
Sub-Saharan Africa1,044,858,0002,483,000110,164,000298,000454,968,0001,204,000

See also


  1. ^ "The global impact of Imperial's COVID-19 Response Team | Imperial News | Imperial College London". Imperial News. Retrieved 18 November 2020.
  2. ^ Wilson, Deborah Evanson, Joanna. "COVID-19: six months on the frontline (An Imperial Story)". Retrieved 18 November 2020.
  3. ^ Landler, Mark; Castle, Stephen (17 March 2020). "Behind the Virus Report That Jarred the U.S. and the U.K. to Action". The New York Times. ISSN 0362-4331. Retrieved 30 March 2020.
  4. ^ "COVID-19 Response Team 2020-2021 report". Imperial College London. Retrieved 23 April 2021.
  5. ^ "People". Imperial College London. Retrieved 18 November 2020.
  6. ^ Adam, David (2020). "Special report: The simulations driving the world's response to COVID-19". Nature. 580 (7803): 316–318. Bibcode:2020Natur.580..316A. doi:10.1038/d41586-020-01003-6. PMID 32242115.
  7. ^ Imperial College COVID-19 Response Team (16 March 2020). "Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand" (PDF).
  8. ^ a b c Imperial College COVID-19 Response Team (30 March 2020). "Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries" (PDF). p. 35.
  9. ^ "COVID-19 reports". Imperial College London. Retrieved 2 May 2021.
  10. ^ "Report 12 - The global impact of COVID-19 and strategies for mitigation and suppression". Imperial College London. Retrieved 4 April 2020.

External links

Media files used on this page

SARS-CoV-2 (Wikimedia colors).svg
Author/Creator: Geraki, Licence: CC BY-SA 4.0
SARS-CoV-2 logo in Wikimedia colors